IS6686A - Hýdrógel-drifið lyfjaskömmtunarform - Google Patents
Hýdrógel-drifið lyfjaskömmtunarformInfo
- Publication number
- IS6686A IS6686A IS6686A IS6686A IS6686A IS 6686 A IS6686 A IS 6686A IS 6686 A IS6686 A IS 6686A IS 6686 A IS6686 A IS 6686A IS 6686 A IS6686 A IS 6686A
- Authority
- IS
- Iceland
- Prior art keywords
- hydrogel
- dosage form
- powered dosage
- powered
- dosage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22419900P | 2000-08-09 | 2000-08-09 | |
PCT/IB2001/001390 WO2002011702A2 (en) | 2000-08-09 | 2001-08-03 | Hydrogel-driven drug dosage form |
Publications (1)
Publication Number | Publication Date |
---|---|
IS6686A true IS6686A (is) | 2003-01-16 |
Family
ID=22839665
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS6686A IS6686A (is) | 2000-08-09 | 2003-01-16 | Hýdrógel-drifið lyfjaskömmtunarform |
Country Status (30)
Country | Link |
---|---|
US (2) | US20030086972A1 (is) |
EP (1) | EP1326587A2 (is) |
JP (1) | JP2004505907A (is) |
KR (1) | KR20030024844A (is) |
CN (1) | CN1461212A (is) |
AP (1) | AP2001002237A0 (is) |
AU (1) | AU2002229141A1 (is) |
BG (1) | BG107538A (is) |
BR (1) | BR0113067A (is) |
CA (1) | CA2418907A1 (is) |
DO (1) | DOP2001000229A (is) |
EA (1) | EA200300081A1 (is) |
EC (1) | ECSP034455A (is) |
EE (1) | EE200300055A (is) |
GT (1) | GT200100161A (is) |
HR (1) | HRP20030082A2 (is) |
HU (1) | HUP0300722A2 (is) |
IL (1) | IL154012A0 (is) |
IS (1) | IS6686A (is) |
MA (1) | MA26939A1 (is) |
MX (1) | MXPA03001209A (is) |
NO (1) | NO20030627L (is) |
OA (1) | OA12365A (is) |
PA (1) | PA8524901A1 (is) |
PE (1) | PE20020307A1 (is) |
PL (1) | PL360658A1 (is) |
SV (1) | SV2002000586A (is) |
TN (1) | TNSN01123A1 (is) |
UY (1) | UY26876A1 (is) |
WO (1) | WO2002011702A2 (is) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0957073A1 (en) | 1998-05-12 | 1999-11-17 | Schwarz Pharma Ag | Novel derivatives of 3,3-diphenylpropylamines |
WO2001047500A1 (en) * | 1999-12-23 | 2001-07-05 | Pfizer Products Inc. | Hydrogel-driven drug dosage form |
AR030557A1 (es) | 2000-04-14 | 2003-08-27 | Jagotec Ag | Una tableta en multicapa de liberacion controlada y metodo de tratamiento |
MXPA03006217A (es) | 2001-01-12 | 2004-10-15 | Sun Pharmaceutical Ind Ltd | Sistema de administracion espaciada de farmacos. |
MXPA04002891A (es) | 2001-09-28 | 2005-06-20 | Johnson & Johnson | Composicion farmaceutica a base de pasta de azucar. |
WO2003096968A2 (en) * | 2002-05-15 | 2003-11-27 | Sun Pharmaceutical Industries Limited | Oral osmotic controlled drug delivery system |
US7785627B2 (en) | 2002-09-20 | 2010-08-31 | Watson Pharmaceuticals, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
US8084058B2 (en) | 2002-09-20 | 2011-12-27 | Watson Pharmaceuticals, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
CA2499597C (en) * | 2002-09-20 | 2012-01-17 | Unchalee Kositprapa | Multistage formulation containing a biguanide and thiazolidindione derivatives |
US7959946B2 (en) | 2002-09-20 | 2011-06-14 | Watson Pharmaceuticals, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
US9060941B2 (en) | 2002-09-20 | 2015-06-23 | Actavis, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
US7807197B2 (en) | 2002-09-28 | 2010-10-05 | Mcneil-Ppc, Inc. | Composite dosage forms having an inlaid portion |
ES2355233T3 (es) * | 2002-09-28 | 2011-03-24 | Mcneil-Ppc, Inc. | Formas de dosificación de liberación modificada con dos núcleos y una abertura. |
FR2850576B1 (fr) | 2003-02-05 | 2007-03-23 | Ethypharm Sa | Composition comprenant un melange de principes actifs, et procede de preparation |
WO2004108067A2 (en) * | 2003-04-03 | 2004-12-16 | Sun Pharmaceutical Industries Limited | Programmed drug delivery system |
DE10315917A1 (de) * | 2003-04-08 | 2004-11-18 | Schwarz Pharma Ag | Hochreine Basen von 3,3-Diphenylpropylaminmonoestern |
AR040157A1 (es) * | 2003-06-06 | 2005-03-16 | Rodriguez Julio Cesar | Una formulacion en microgranulos para administracion oral en suspension acuosa |
CA2534371A1 (en) * | 2003-08-04 | 2005-02-10 | Pfizer Products Inc. | Dosage forms providing controlled release of cholesteryl ester transfer protein inhibitors and immediate release of hmg-coa reductase inhibitors |
US7879354B2 (en) | 2004-01-13 | 2011-02-01 | Mcneil-Ppc, Inc. | Rapidly disintegrating gelatinous coated tablets |
US8067029B2 (en) | 2004-01-13 | 2011-11-29 | Mcneil-Ppc, Inc. | Rapidly disintegrating gelatinous coated tablets |
US20080145427A1 (en) * | 2005-02-03 | 2008-06-19 | Alfred Berchielli | Dosage Forms Providing Controlled and Immediate Release of Cholesteryl Ester Transfer Protein Inhibitors and Immediate Release of Hmg-Coa Reductase Inhibitors |
US20060193911A1 (en) * | 2005-02-28 | 2006-08-31 | Penwest Pharmaceuticals Co., | Controlled release venlafaxine formulations |
CA2601800C (en) * | 2005-03-14 | 2013-12-03 | Nitin Bhalachandra Dharmadhikari | Oral drug delivery system |
WO2006099618A1 (en) * | 2005-03-16 | 2006-09-21 | Dr. Reddy's Laboratories Ltd. | Delivery system for multiple drugs |
US8673352B2 (en) | 2005-04-15 | 2014-03-18 | Mcneil-Ppc, Inc. | Modified release dosage form |
CN100448433C (zh) * | 2005-09-21 | 2009-01-07 | 广州贝氏药业有限公司 | 一种克拉霉素肠溶药物组合物 |
US20070248630A1 (en) * | 2006-04-20 | 2007-10-25 | Friden Phillip M | Pharmaceutical formulations for iontophoretic methotrexate delivery |
SA07280459B1 (ar) * | 2006-08-25 | 2011-07-20 | بيورديو فارما إل. بي. | أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني |
KR20080076382A (ko) * | 2007-02-15 | 2008-08-20 | (주)아모레퍼시픽 | 실로스타졸의 제어방출 제제 및 그 제조방법 |
EP2242485A4 (en) * | 2008-02-15 | 2013-05-08 | Sun Pharma Advanced Res Co Ltd | ORAL TABLET WITH CONTROLLED RELEASE |
CN102711741A (zh) * | 2009-11-09 | 2012-10-03 | 比利时胶囊公司 | 递送载体 |
BR112012023654B1 (pt) | 2010-03-19 | 2022-04-12 | Daiichi Sankyo Company, Limited | Método para produzir grânulos contendo agente anticoagulante e método para produzir uma composição farmacêutica contendo o dito agente |
CA2844604C (en) * | 2011-08-10 | 2017-07-18 | Daiichi Sankyo Company, Limited | Pharmaceutical composition containing ethanediamide derivatives |
HUE045625T2 (hu) * | 2013-01-30 | 2019-12-30 | Daewoong Co Ltd | Gyógyászati kompozíciók sebek védelmére, vérpangás szolgáltatására, vagy összetapadás megakadályozására a gyomor- és bél traktusban |
MA41868A (fr) * | 2015-04-01 | 2018-02-06 | Spectrum Brands Inc | Pastille retard et procédés s'y rapportant |
CA3088017A1 (en) | 2018-03-07 | 2019-09-12 | Andrew Xian Chen | Aqueous formulations for insoluble drugs |
WO2022251620A1 (en) * | 2021-05-28 | 2022-12-01 | Amgen Inc. | Formulations of apremilast |
CN113600179B (zh) * | 2021-09-16 | 2023-07-04 | 山东博霖环保科技发展有限公司 | 一种脱硝催化剂及其制备方法 |
TW202325285A (zh) * | 2021-10-14 | 2023-07-01 | 靜岡縣公立大學法人 | 粉末製劑 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1025765B (it) * | 1974-11-18 | 1978-08-30 | Gastaldi Francesco | Essiccatore perfezionato a spruzzo |
US4187617A (en) * | 1978-12-18 | 1980-02-12 | Becker James J Jr | Spray dryer |
US4327725A (en) * | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
US4449983A (en) * | 1982-03-22 | 1984-05-22 | Alza Corporation | Simultaneous delivery of two drugs from unit delivery device |
US4612008A (en) * | 1983-05-11 | 1986-09-16 | Alza Corporation | Osmotic device with dual thermodynamic activity |
US4624848A (en) * | 1984-05-10 | 1986-11-25 | Ciba-Geigy Corporation | Active agent containing hydrogel devices wherein the active agent concentration profile contains a sigmoidal concentration gradient for improved constant release, their manufacture and use |
US4851232A (en) * | 1987-02-13 | 1989-07-25 | Alza Corporation | Drug delivery system with means for obtaining desirable in vivo release rate pattern |
GB8820353D0 (en) * | 1988-08-26 | 1988-09-28 | Staniforth J N | Controlled release tablet |
US5612059A (en) * | 1988-08-30 | 1997-03-18 | Pfizer Inc. | Use of asymmetric membranes in delivery devices |
US5096716A (en) * | 1988-09-01 | 1992-03-17 | Alza Corporation | Dosage form for administering calcium antagonist nicardipine |
US5030452A (en) * | 1989-01-12 | 1991-07-09 | Pfizer Inc. | Dispensing devices powered by lyotropic liquid crystals |
IL92966A (en) * | 1989-01-12 | 1995-07-31 | Pfizer | Hydrogel-operated release devices |
US5120548A (en) * | 1989-11-07 | 1992-06-09 | Merck & Co., Inc. | Swelling modulated polymeric drug delivery device |
JPH05178763A (ja) * | 1991-02-19 | 1993-07-20 | Nippon Saafuakutanto Kogyo Kk | 難溶解性薬物溶解剤組成物 |
PT758244E (pt) * | 1994-05-06 | 2002-04-29 | Pfizer | Formas de dosagem libertacao controlada de azitromicina |
US5654005A (en) * | 1995-06-07 | 1997-08-05 | Andrx Pharmaceuticals, Inc. | Controlled release formulation having a preformed passageway |
TW487582B (en) * | 1995-08-11 | 2002-05-21 | Nissan Chemical Ind Ltd | Method for converting sparingly water-soluble medical substance to amorphous state |
UA67741C2 (uk) * | 1997-07-01 | 2004-07-15 | Пфайзер Продактс Інк. | Солюбілізовані композиції сертраліну |
NZ501251A (en) * | 1997-07-01 | 2001-09-28 | Pfizer | Sertraline salts and sustained-release dosage forms of sertraline |
DE19747261A1 (de) * | 1997-10-25 | 1999-04-29 | Bayer Ag | Osmotisches Arzneimittelfreisetzungssystem |
US6037346A (en) * | 1997-10-28 | 2000-03-14 | Vivus, Inc. | Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction |
CA2346335C (en) * | 1998-10-13 | 2006-04-18 | Pfizer Products Inc. | Sertraline oral concentrate |
EP1027888B1 (en) * | 1999-02-10 | 2009-06-10 | Pfizer Products Inc. | Osmotic system for delivery of solid amorphous dispersions of drugs |
US6500459B1 (en) * | 1999-07-21 | 2002-12-31 | Harinderpal Chhabra | Controlled onset and sustained release dosage forms and the preparation thereof |
US20010053791A1 (en) * | 2000-03-16 | 2001-12-20 | Babcock Walter C. | Glycogen phosphorylase inhibitor |
WO2004052343A1 (en) * | 2002-12-11 | 2004-06-24 | Pfizer Products Inc. | Controlled-release of an active substance into a high fat environment |
-
2001
- 2001-08-01 US US09/920,056 patent/US20030086972A1/en not_active Abandoned
- 2001-08-03 JP JP2002517039A patent/JP2004505907A/ja active Pending
- 2001-08-03 BR BR0113067-6A patent/BR0113067A/pt not_active IP Right Cessation
- 2001-08-03 MX MXPA03001209A patent/MXPA03001209A/es not_active Application Discontinuation
- 2001-08-03 AP APAP/P/2001/002237A patent/AP2001002237A0/en unknown
- 2001-08-03 IL IL15401201A patent/IL154012A0/xx unknown
- 2001-08-03 OA OA1200300043A patent/OA12365A/en unknown
- 2001-08-03 EA EA200300081A patent/EA200300081A1/ru unknown
- 2001-08-03 CN CN01816024A patent/CN1461212A/zh active Pending
- 2001-08-03 AU AU2002229141A patent/AU2002229141A1/en not_active Abandoned
- 2001-08-03 KR KR10-2003-7001861A patent/KR20030024844A/ko not_active Application Discontinuation
- 2001-08-03 PL PL36065801A patent/PL360658A1/xx not_active Application Discontinuation
- 2001-08-03 CA CA002418907A patent/CA2418907A1/en not_active Abandoned
- 2001-08-03 HU HU0300722A patent/HUP0300722A2/hu unknown
- 2001-08-03 EP EP01984471A patent/EP1326587A2/en not_active Withdrawn
- 2001-08-03 WO PCT/IB2001/001390 patent/WO2002011702A2/en not_active Application Discontinuation
- 2001-08-03 US US10/344,171 patent/US20040052845A1/en not_active Abandoned
- 2001-08-03 EE EEP200300055A patent/EE200300055A/xx unknown
- 2001-08-08 DO DO2001000229A patent/DOP2001000229A/es unknown
- 2001-08-08 GT GT200100161A patent/GT200100161A/es unknown
- 2001-08-08 PE PE2001000791A patent/PE20020307A1/es not_active Application Discontinuation
- 2001-08-08 UY UY26876A patent/UY26876A1/es not_active Application Discontinuation
- 2001-08-08 TN TNTNSN01123A patent/TNSN01123A1/fr unknown
- 2001-08-08 SV SV2001000586A patent/SV2002000586A/es not_active Application Discontinuation
- 2001-08-09 PA PA20018524901A patent/PA8524901A1/es unknown
-
2003
- 2003-01-16 IS IS6686A patent/IS6686A/is unknown
- 2003-01-28 EC EC2003004455A patent/ECSP034455A/es unknown
- 2003-01-29 MA MA27017A patent/MA26939A1/fr unknown
- 2003-02-06 HR HR20030082A patent/HRP20030082A2/hr not_active Application Discontinuation
- 2003-02-06 BG BG107538A patent/BG107538A/bg unknown
- 2003-02-07 NO NO20030627A patent/NO20030627L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PA8524901A1 (es) | 2002-04-25 |
EE200300055A (et) | 2004-12-15 |
SV2002000586A (es) | 2002-10-24 |
JP2004505907A (ja) | 2004-02-26 |
PL360658A1 (en) | 2004-09-20 |
NO20030627D0 (no) | 2003-02-07 |
PE20020307A1 (es) | 2002-04-23 |
HUP0300722A2 (hu) | 2003-11-28 |
ECSP034455A (es) | 2003-03-10 |
HRP20030082A2 (en) | 2003-04-30 |
OA12365A (en) | 2006-05-16 |
MXPA03001209A (es) | 2003-06-30 |
BG107538A (bg) | 2003-11-28 |
KR20030024844A (ko) | 2003-03-26 |
EA200300081A1 (ru) | 2003-08-28 |
BR0113067A (pt) | 2003-07-01 |
US20030086972A1 (en) | 2003-05-08 |
DOP2001000229A (es) | 2002-09-30 |
UY26876A1 (es) | 2002-03-22 |
CA2418907A1 (en) | 2002-02-14 |
NO20030627L (no) | 2003-04-08 |
AU2002229141A1 (en) | 2002-02-18 |
US20040052845A1 (en) | 2004-03-18 |
TNSN01123A1 (fr) | 2005-11-10 |
IL154012A0 (en) | 2003-07-31 |
EP1326587A2 (en) | 2003-07-16 |
MA26939A1 (fr) | 2004-12-20 |
WO2002011702A2 (en) | 2002-02-14 |
CN1461212A (zh) | 2003-12-10 |
WO2002011702A3 (en) | 2002-11-28 |
GT200100161A (es) | 2002-03-22 |
AP2001002237A0 (en) | 2001-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS6686A (is) | Hýdrógel-drifið lyfjaskömmtunarform | |
DE60038698D1 (de) | Hydrogel-gesteuerte dosierungsform | |
ATE290000T1 (de) | Muscarinagonisten | |
ATE252099T1 (de) | Biarylcarboxamide | |
DE10136334B8 (de) | Hochgeschwindigkeitsvertikalresonatoroberflächenemissionslaser | |
DK1524266T3 (da) | Farmaceutisk sammensætning | |
ATE312098T1 (de) | Thiazinoxazolidinon | |
ATA2932001A (de) | Schneefräse | |
EE200200420A (et) | Linesoliid - kristallivorm II | |
ATE262530T1 (de) | Indolochinazolinone | |
ATE298751T1 (de) | 7-oxopyridoryrimidine | |
AR028336A1 (es) | 4-hidroxi-tetrahidropiridonas fenilsubstituidas | |
DE10192638T1 (de) | Bohrstangenladevorrichtung | |
ATE509008T1 (de) | Sulfonylguanidine | |
DE10196064T1 (de) | Halbleiterfotodektionsgerät | |
AR028061A1 (es) | 2-enamino-cetonitrilos fenil-substituidos | |
AR027931A1 (es) | Antitranspirantes | |
DE10052925B4 (de) | Schaukelbett | |
ATE476423T1 (de) | Benzoylpyridazine | |
DE50007634D1 (de) | Kardioplegieballonkatheter | |
DE10195909T1 (de) | Viehfüttervorrichtung | |
DE10085445T1 (de) | Drahterodierbearbeitungseinrichtung | |
AR027982A1 (es) | Aril- y heteroarilsulfonatos | |
DE10195992T1 (de) | Oberflächenendbearbeitungsbelag | |
ATE284887T1 (de) | Thienopyrrolidinone |